Pillstats
Rx only · Tablet, Film Coated · Oral

Amlodipine Besylate And Olmesartran Medoxomil

Amlodipine Besylate + Olmesartan Medoxomil

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US8 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCC09CA08
RxCUI (US)118463
US makers1 labelers
Packages24
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 8 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.088$0.177$0.265$0.354Dec 2025Apr 2026Jul 2026
$0.279
Latest avg · Jul 22, 2026
-8%
Since Dec 17, 2025
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2.3K4.6K7.0K9.3K2025 Q12025 Q22025 Q32025 Q42026 Q1
8.1K
Rx · 2026 Q1
400K
Units dispensed
+69%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Alembic Pharmaceuticals Limitedunknown24SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.